Showing results (201-210 of 426) with videos related to
Sort By:
Pageof 43
Pediatric Nephrology (Berlin, Germany)|August 1, 1995
Role of platelets in progressive glomerular diseasesC Zoja, G RemuzziAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1996
Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomyP Ruggenenti, G RemuzziClinical and Experimental Immunology|December 12, 2007
Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritisM Noris, G RemuzziDiabetes Research and Clinical Practice|July 3, 1998
Prognosis of diabetic nephropathy: how to improve the outcomeG Remuzzi, P RuggenentiThe Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.European Journal of Clinical Investigation|April 2, 2009
Endothelin receptor selectivity in chronic renal failureL Longaretti, A BenigniClinical and Experimental Pharmacology & Physiology|April 1, 1996
Endothelin is a key modulator of progressive renal injury: experimental data and novel therapeutic strategiesI Bruzzi, A BenigniCurrent Gene Therapy|March 23, 2004
Gene therapy: how to target the kidney. Promises and pitfallsS Tomasoni, A BenigniAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 10, 2017
Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell ResponseF Casiraghi, N Azzollini, M Todeschini, et al.Pageof 43